{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:35:09Z","timestamp":1777336509158,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12012-026-10110-1","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T02:43:19Z","timestamp":1776048199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Large-Scale Signal Detection and Personalized Risk Prediction for Cardiovascular Drug Adverse Reactions in Elderly Patients: Real-World Evidence from Western China"],"prefix":"10.1007","volume":"26","author":[{"given":"Zimeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzhi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"10110_CR1","unstructured":"WHO. (2024). Ageing and health [EB\/OL]. https:\/\/www.who.int\/china\/zh\/health-topics\/ageing"},{"issue":"10367","key":"10110_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0140-6736(22)01546-X","volume":"400","author":"X Chen","year":"2022","unstructured":"Chen, X., Giles, J., Yao, Y., Yip, W., Meng, Q., Berkman, L., et al. (2022). The path to healthy ageing in China: A Peking University-Lancet Commission. Lancet, 400(10367), 1967\u20132006. https:\/\/doi.org\/10.1016\/S0140-6736(22)01546-X","journal-title":"Lancet"},{"issue":"1","key":"10110_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19010207","volume":"19","author":"L Cium\u0103rnean","year":"2021","unstructured":"Cium\u0103rnean, L., Milaciu, M. V., Negrean, V., Or\u0103\u0219an, O. H., Vesa, S. C., S\u0103l\u0103gean, O., et al. (2021). Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly. International Journal of Environmental Research and Public Health, 19(1), Article 207. https:\/\/doi.org\/10.3390\/ijerph19010207","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10110_CR4","unstructured":"National Centre for Cardiovascular DiseasesChina Cardiovascular Health and Disease Report 2023 [EB\/OL].(2024-11-25) [2025-8-5]. https:\/\/www.nccd.org.cn\/Search\/Index?keyword=%E4%B8%AD%E5%9B%BD%E5%BF%83%E8%A1%80%E7%AE%A1%E5%81%A5%E5%BA%B7%E4%B8%8E%E7%96%BE%E7%97%85%E6%8A%A5%E5%91%8A2023&page=1"},{"issue":"2","key":"10110_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/bcpt.13426","volume":"127","author":"L Liberale","year":"2020","unstructured":"Liberale, L., Kraler, S., Camici, G. G., & L\u00fcscher, T. F. (2020). Ageing and longevity genes in cardiovascular diseases. Basic & Clinical Pharmacology & Toxicology, 127(2), 120\u2013131. https:\/\/doi.org\/10.1111\/bcpt.13426","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"12","key":"10110_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cpcardiol.2008.08.002","volume":"33","author":"MD Faulx","year":"2008","unstructured":"Faulx, M. D., & Francis, G. S. (2008). Adverse drug reactions in patients with cardiovascular disease. Current Problems in Cardiology, 33(12), 703\u201368. https:\/\/doi.org\/10.1016\/j.cpcardiol.2008.08.002","journal-title":"Current Problems in Cardiology"},{"issue":"7","key":"10110_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/138920011796504563","volume":"12","author":"G Onder","year":"2011","unstructured":"Onder, G., Lattanzio, F., Battaglia, M., Cerullo, F., Sportiello, R., Bernabei, R., & Landi, F. (2011). The risk of adverse drug reactions in older patients: Beyond drug metabolism. Curr Drug Metab, 12(7), 647\u201351. https:\/\/doi.org\/10.2174\/138920011796504563","journal-title":"Curr Drug Metab"},{"issue":"1","key":"10110_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74505-2","volume":"14","author":"A Farnoush","year":"2024","unstructured":"Farnoush, A., Sedighi-Maman, Z., Rasoolian, B., Heath, J. J., & Fallah, B. (2024). Prediction of adverse drug reactions using demographic and non-clinical drug characteristics in FAERS data. Sci Rep, 14(1), Article 23636. https:\/\/doi.org\/10.1038\/s41598-024-74505-2","journal-title":"Sci Rep"},{"key":"10110_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2024-004352","author":"L Tsui","year":"2025","unstructured":"Tsui, L., Wang, D., Fan, C., Huang, Y., Zhang, Z., Fang, Z., & Xie, W. (2025). Evaluation of statin-induced muscle and liver adverse drug reactions in the Chinese population: A retrospective analysis of clinical trial data from 1992 to 2023. Eur J Hosp Pharm, . https:\/\/doi.org\/10.1136\/ejhpharm-2024-004352","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"10110_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10557-021-07157-3","volume":"36","author":"NM Patel","year":"2022","unstructured":"Patel, N. M., Stottlemyer, B. A., Gray, M. P., Boyce, R. D., & Kane-Gill, S. L. (2022). A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Cardiovasc Drugs Ther, 36(2), 309\u2013322. https:\/\/doi.org\/10.1007\/s10557-021-07157-3","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"10110_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.therap.2017.08.006","volume":"73","author":"JL Faillie","year":"2018","unstructured":"Faillie, J. L. (2018). Les \u00e9tudes cas\u2013non cas\u202f: principe, m\u00e9thodes, biais et interpr\u00e9tations [Case-non case studies: Principles, methods, bias and interpretation]. Therapie, 73(3), 247\u2013255. https:\/\/doi.org\/10.1016\/j.therap.2017.08.006","journal-title":"Therapie"},{"issue":"1","key":"10110_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-55829-5","volume":"14","author":"R Sun","year":"2024","unstructured":"Sun, R., Ning, Z., Qin, H., Zhang, W., Teng, Y., Jin, C., Liu, J., & Wang, A. (2024). A real-world pharmacovigilance study of amivantamab-related cardiovascular adverse events based on the FDA adverse event reporting system (FAERS) database. Scientific Reports, 14(1), Article 9552. https:\/\/doi.org\/10.1038\/s41598-024-55829-5","journal-title":"Scientific Reports"},{"key":"10110_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.988013","volume":"9","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Cui, C., Ren, X., Dong, X., & Cui, W. (2022). Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to 2021. Frontiers in Cardiovascular Medicine, 9, Article 988013. https:\/\/doi.org\/10.3389\/fcvm.2022.988013","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"10110_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","volume":"55","author":"J Gauthier","year":"2020","unstructured":"Gauthier, J., Wu, Q. V., & Gooley, T. A. (2020). Cubic splines to model relationships between continuous variables and outcomes: A guide for clinicians. Bone Marrow Transplant, 55(4), 675\u2013680. https:\/\/doi.org\/10.1038\/s41409-019-0679-x","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10110_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4103\/jcrt.jcrt_1690_24","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang, J., Zhang, K., Tang, X., Chen, Y., & Ye, Z. (2025). Restricted cubic spline analysis: Age-dependent relationship between MAGEA12 and hepatocellular carcinoma prognosis. Journal of Cancer Research and Therapeutics, 21(2), 457\u2013464. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1690_24","journal-title":"Journal of Cancer Research and Therapeutics"},{"key":"10110_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mdr2.70015","author":"HB Xu","year":"2025","unstructured":"Xu, H. B., Chen, C., Lu, Z. X., et al. (2025). rcssci: An R Package for Visualization of Restricted Cubic Spline. Med Research. https:\/\/doi.org\/10.1002\/mdr2.70015","journal-title":"Med Research"},{"issue":"9(Suppl 9)","key":"10110_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-S9-S7","volume":"11","author":"R Harpaz","year":"2010","unstructured":"Harpaz, R., Chase, H. S., & Friedman, C. (2010). Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics, 11(9(Suppl 9)), Article S7. https:\/\/doi.org\/10.1186\/1471-2105-11-S9-S7","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"10110_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059241","volume":"8","author":"DH Yang","year":"2013","unstructured":"Yang, D. H., Kang, J. H., Park, Y. B., Park, Y. J., Oh, H. S., & Kim, S. B. (2013). Association rule mining and network analysis in oriental medicine. PLoS One, 8(3), Article e59241. https:\/\/doi.org\/10.1371\/journal.pone.0059241","journal-title":"PLoS One"},{"key":"10110_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/CIN.0000000000001348","author":"M Wu","year":"2025","unstructured":"Wu, M., Zhang, X., Yu, H., & Pan, H. (2025). Mining Association Rules Between Pressure Injury Risk Factors in Adult Inpatients Based on the Apriori Algorithm. Comput Inform Nurs. https:\/\/doi.org\/10.1097\/CIN.0000000000001348","journal-title":"Comput Inform Nurs"},{"issue":"15","key":"10110_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154280","volume":"11","author":"D Liccardo","year":"2022","unstructured":"Liccardo, D., Arosio, B., Corbi, G., & Cannavo, A. (2022). Sex\/Gender- and age-related differences in \u03b2-adrenergic receptor signaling in cardiovascular diseases. Journal of Clinical Medicine, 11(15), Article 4280. https:\/\/doi.org\/10.3390\/jcm11154280","journal-title":"Journal of Clinical Medicine"},{"key":"10110_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112420","volume":"190","author":"G Corbi","year":"2024","unstructured":"Corbi, G., Comegna, M., Vinciguerra, C., Capasso, A., Onorato, L., Salucci, A. M., et al. (2024). Age and sex mediated effects of estrogen and \u03923-adrenergic receptor on cardiovascular pathophysiology. Experimental Gerontology, 190, Article 112420. https:\/\/doi.org\/10.1016\/j.exger.2024.112420","journal-title":"Experimental Gerontology"},{"issue":"8\u20139","key":"10110_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.exger.2005.06.009","volume":"40","author":"DL Schmucker","year":"2005","unstructured":"Schmucker, D. L. (2005). Age-related changes in liver structure and function: Implications for disease ?[J]. Experimental Gerontology, 40(8\u20139), 650\u2013659.","journal-title":"Experimental Gerontology"},{"key":"10110_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105812","volume":"162","author":"Z Vinarov","year":"2021","unstructured":"Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., et al. (2021). Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review. European Journal of Pharmaceutical Sciences, 162, Article 105812. https:\/\/doi.org\/10.1016\/j.ejps.2021.105812","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10110_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jcpt.13024","volume":"45","author":"S Kinoshita","year":"2020","unstructured":"Kinoshita, S., Hosomi, K., Yokoyama, S., & Takada, M. (2020). Time-to-onset analysis of amiodarone-associated thyroid dysfunction. Journal of Clinical Pharmacy and Therapeutics, 45(1), 65\u201371. https:\/\/doi.org\/10.1111\/jcpt.13024","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10110_CR25","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/IJGM.S460305","volume":"17","author":"MM Ma","year":"2024","unstructured":"Ma, M. M., Xu, Y. Y., Sun, L. H., Cui, W. J., Fan, M., Zhang, S., et al. (2024). Statin-associated liver dysfunction and muscle injury: Epidemiology, mechanisms, and management strategies. International Journal of General Medicine, 17, 2055\u20132063. https:\/\/doi.org\/10.2147\/IJGM.S460305","journal-title":"International Journal of General Medicine"},{"issue":"1","key":"10110_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14740338.2018.1394455","volume":"17","author":"S Bellosta","year":"2018","unstructured":"Bellosta, S., & Corsini, A. (2018). Statin drug interactions and related adverse reactions: An update. Expert Opinion on Drug Safety, 17(1), 25\u201337. https:\/\/doi.org\/10.1080\/14740338.2018.1394455","journal-title":"Expert Opinion on Drug Safety"},{"issue":"1","key":"10110_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/JND-170282","volume":"5","author":"P Mohassel","year":"2018","unstructured":"Mohassel, P., & Mammen, A. L. (2018). Anti-HMGCR Myopathy. Journal of Neuromuscular Diseases, 5(1), 11\u201320. https:\/\/doi.org\/10.3233\/JND-170282","journal-title":"Journal of Neuromuscular Diseases"},{"issue":"21","key":"10110_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111687","volume":"22","author":"P Vinci","year":"2021","unstructured":"Vinci, P., Panizon, E., Tosoni, L. M., et al. (2021). Statin-associated myopathy: Emphasis on mechanisms and targeted therapy. International Journal of Molecular Sciences, 22(21), Article 11687. https:\/\/doi.org\/10.3390\/ijms222111687","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10110_CR29","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1111\/bcp.15757","volume":"89","author":"JL Montastruc","year":"2023","unstructured":"Montastruc, J. L. (2023). Rhabdomyolysis and statins: A pharmacovigilance comparative study between statins. British Journal of Clinical Pharmacology, 89(8), 2636\u20132638. https:\/\/doi.org\/10.1111\/bcp.15757","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"10110_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00228-024-03787-2","volume":"81","author":"AA Pandit","year":"2025","unstructured":"Pandit, A. A., Desai, B. V., & Vyas, B. A. (2025). Peripheral edema induced by isosorbide mononitrate in an elderly patient: A case study of dose-related risks and drug interactions. European Journal of Clinical Pharmacology, 81(2), 333\u2013336. https:\/\/doi.org\/10.1007\/s00228-024-03787-2","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"10110_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ihj.2020.08.007","volume":"72","author":"B Pinto","year":"2020","unstructured":"Pinto, B., Jadhav, U., Singhai, P., Sadhanandham, S., & Shah, N. (2020). ACEI-induced cough: A review of current evidence and its practical implications for optimal CV risk reduction. Indian Heart J, 72(5), 345\u2013350. https:\/\/doi.org\/10.1016\/j.ihj.2020.08.007","journal-title":"Indian Heart J"},{"key":"10110_CR32","unstructured":"Lee, P. M., & Gerriets, V. N. (2023). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan&#8211."},{"issue":"4","key":"10110_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10557-016-6668-z","volume":"30","author":"JM Tarkin","year":"2016","unstructured":"Tarkin, J. M., & Kaski, J. C. (2016). Vasodilator therapy: Nitrates and Nicorandil. Cardiovascular Drugs and Therapy, 30(4), 367\u2013378. https:\/\/doi.org\/10.1007\/s10557-016-6668-z","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"1","key":"10110_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/pds.5547","volume":"32","author":"EK Acton","year":"2023","unstructured":"Acton, E. K., Willis, A. W., & Hennessy, S. (2023). Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies. Pharmacoepidemiology and Drug Safety, 32(1), 9\u201318. https:\/\/doi.org\/10.1002\/pds.5547","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"6","key":"10110_CR35","doi-asserted-by":"publisher","DOI":"10.2174\/011573403X338702250226075044","volume":"21","author":"A Shrivastava","year":"2025","unstructured":"Shrivastava, A., Gokhale, N., Paliwal, P., Dwivedi, S., Khan, S., Nikam, P. L., et al. (2025). Heart failure management in the modern era: A comprehensive review on medical and device-based interventions. Current Cardiology Reviews, 21(6), Article e1573403X338702. https:\/\/doi.org\/10.2174\/011573403X338702250226075044","journal-title":"Current Cardiology Reviews"},{"issue":"7","key":"10110_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/jech-2019-213435","volume":"74","author":"A H\u00f6hn","year":"2020","unstructured":"H\u00f6hn, A., Gampe, J., Lindahl-Jacobsen, R., Christensen, K., & Oksuyzan, A. (2020). Do men avoid seeking medical advice? A register-based analysis of gender-specific changes in primary healthcare use after first hospitalisation at ages 60\u2009+\u2009in Denmark. Journal of Epidemiology and Community Health, 74(7), 573\u2013579. https:\/\/doi.org\/10.1136\/jech-2019-213435","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"12","key":"10110_CR37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s40264-017-0581-7","volume":"40","author":"RB Weinstein","year":"2017","unstructured":"Weinstein, R. B., Ryan, P., Berlin, J. A., Matcho, A., Schuemie, M., Swerdel, J., et al. (2017). Channeling in the use of nonprescription paracetamol and ibuprofen in an electronic medical records database: Evidence and implications. Drug Safety, 40(12), 1279\u20131292. https:\/\/doi.org\/10.1007\/s40264-017-0581-7","journal-title":"Drug Safety"},{"issue":"3","key":"10110_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0018578719882323","volume":"56","author":"R Neha","year":"2021","unstructured":"Neha, R., Subeesh, V., Beulah, E., Gouri, N., & Maheswari, E. (2021). Existence of notoriety bias in FDA Adverse Event Reporting System database and its impact on signal strength. Hospital Pharmacy, 56(3), 152\u2013158. https:\/\/doi.org\/10.1177\/0018578719882323","journal-title":"Hospital Pharmacy"},{"issue":"11","key":"10110_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40264-014-0225-0","volume":"37","author":"KB Hoffman","year":"2014","unstructured":"Hoffman, K. B., Demakas, A. R., Dimbil, M., Tatonetti, N. P., & Erdman, C. B. (2014). Stimulated reporting: The impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS). Drug Safety, 37(11), 971\u201380. https:\/\/doi.org\/10.1007\/s40264-014-0225-0","journal-title":"Drug Safety"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-026-10110-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-026-10110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:37:07Z","timestamp":1777333027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-026-10110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10110"],"URL":"https:\/\/doi.org\/10.1007\/s12012-026-10110-1","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required for the study involving humans in accordance with the local legislation and institutional requirements. Written informed consent to participate in this study was not required from the participants or the participants\u2019 legal guardians\/next of kin in accordance with the national legislation and the institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"41"}}